Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
pfizer ltd stock

PFIZER LTD Share Price

5127.9 -50.64 (-0.97%)
Nov 21 2024 03:29 PM Pharmaceuticals NSE: PFIZER

PFIZER LTD Share Price Update

As of the latest trading session, PFIZER LTD share price is currently at 5127.9, which is down by -50.64 from its previous closing. Today, the stock has fluctuated between 5100.00 and 5210.65. Over the past year, PFIZER LTD has achieved a return of 29.88 %. In the last month alone, the return has been -7.49 %. Read More...

PFIZER LTD Performance

Day Range

Low5100.00 High5210.65
5131.30

52 Week Range

Low 3950.00 High 6451.15
5131.30

PFIZER LTD Share Price

2643

500680

PFIZER

img img img img
No Data Available

Open Price

5188.65

Prev. Close

5178.55

Volume (Shares)

10111.00

Total traded value

518.82

Upper Circuit

6214.25

Lower Circuit

4142.85

Note: The current prices & values are delayed, Login to your account for live updates.

PFIZER LTD Fundamentals


(Standalone)

Market Cap (Cr) 23474.50
PE Ratio (TTM) 38.38
Book Value / Share 819.90
Beta 0.25
ROE 16.21%
EPS (TTM) 133.78
Dividend Yield 0.68%
Net Profit Qtr (Cr) 158.35

PFIZER LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 588.59
Operating Expense 416.43
Net Profit 158.35
Net Profit Margin (%) 26.90
Earnings Per Share (EPS) 34.61
EBITDA 232.32
Effective Tax Rate (%) 26.42
Particulars JUN 2024 (Values in Cr)
Revenue 562.86
Operating Expense 402.08
Net Profit 150.71
Net Profit Margin (%) 26.77
Earnings Per Share (EPS) 32.94
EBITDA 219.33
Effective Tax Rate (%) 25.61
Particulars MAR 2024 (Values in Cr)
Revenue 546.63
Operating Expense 377.90
Net Profit 178.86
Net Profit Margin (%) 32.72
Earnings Per Share (EPS) 39.09
EBITDA 264.56
Effective Tax Rate (%) 26.65
Particulars DEC 2023 (Values in Cr)
Revenue 539.97
Operating Expense 407.83
Net Profit 129.98
Net Profit Margin (%) 24.07
Earnings Per Share (EPS) 28.42
EBITDA 196.35
Effective Tax Rate (%) 26.12
Particulars SEP 2023 (Values in Cr)
Revenue 575.21
Operating Expense 410.76
Net Profit 148.96
Net Profit Margin (%) 25.89
Earnings Per Share (EPS) 32.56
EBITDA 218.68
Effective Tax Rate (%) 25.71
Particulars MAR 2024 (Values in Cr)
Revenue 2193.17
Operating Expense 1635.56
Net Profit 551.33
Net Profit Margin (%) 25.13
Earnings Per Share (EPS) 120.51
EBITDA 823.76
Effective Tax Rate (%) 26.10
Particulars MAR 2023 (Values in Cr)
Revenue 2424.76
Operating Expense 1734.80
Net Profit 623.93
Net Profit Margin (%) 25.73
Earnings Per Share (EPS) 128.50
EBITDA 942.91
Effective Tax Rate (%) 24.28
Particulars MAR 2022 (Values in Cr)
Revenue 2610.99
Operating Expense 1900.75
Net Profit 612.56
Net Profit Margin (%) 23.46
Earnings Per Share (EPS) 133.89
EBITDA 898.38
Effective Tax Rate (%) 20.74
Particulars MAR 2021 (Values in Cr)
Revenue 2238.55
Operating Expense 1650.94
Net Profit 497.61
Net Profit Margin (%) 22.22
Earnings Per Share (EPS) 108.77
EBITDA 793.24
Effective Tax Rate (%) 25.58
Particulars MAR 2020 (Values in Cr)
Revenue 2151.65
Operating Expense 1693.17
Net Profit 509.13
Net Profit Margin (%) 23.66
Earnings Per Share (EPS) 111.28
EBITDA 756.58
Effective Tax Rate (%) 20.75
Particulars (Values in Cr)
Book Value / Share 301.97
ROE % 19.78
ROCE % 27.27
Total Debt to Total Equity 0.00
EBITDA Margin 28.89
Particulars (Values in Cr)
Book Value / Share 217.73
ROE % 27.44
ROCE % 37.35
Total Debt to Total Equity 0.00
EBITDA Margin 26.20
Particulars (Values in Cr)
Book Value / Share 135.97
ROE % 27.21
ROCE % 44.48
Total Debt to Total Equity 0.00
EBITDA Margin 22.81
Particulars (Values in Cr)
Book Value / Share 125.99
ROE % 23.74
ROCE % 42.64
Total Debt to Total Equity 0.02
EBITDA Margin 21.12
Particulars (Values in Cr)
Book Value / Share 117.53
ROE % 17.39
ROCE % 34.75
Total Debt to Total Equity 0.02
EBITDA Margin 15.05
Particulars MAR 2024 (Values in Cr)
Book Value / Share 785.91
ROE % 16.21
ROCE % 21.43
Total Debt to Total Equity 0.01
EBITDA Margin 37.56
Particulars MAR 2023 (Values in Cr)
Book Value / Share 701.05
ROE % 20.55
ROCE % 25.88
Total Debt to Total Equity 0.01
EBITDA Margin 38.89
Particulars MAR 2022 (Values in Cr)
Book Value / Share 626.10
ROE % 23.30
ROCE % 27.78
Total Debt to Total Equity 0.02
EBITDA Margin 34.42
Particulars MAR 2021 (Values in Cr)
Book Value / Share 523.07
ROE % 17.19
ROCE % 22.47
Total Debt to Total Equity 0.01
EBITDA Margin 35.45
Particulars MAR 2020 (Values in Cr)
Book Value / Share 742.18
ROE % 15.89
ROCE % 19.85
Total Debt to Total Equity 0.00
EBITDA Margin 35.17
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2046.71
Total Assets 4228.78
Total Liabilities 4228.78
Total Equity 3595.54
Share Outstanding 45750372
Price to Book Ratio 5.34
Return on Assets (%) 13.03
Return on Capital (%) 15.32
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1859.52
Total Assets 4000.73
Total Liabilities 4000.73
Total Equity 3207.30
Share Outstanding 45750372
Price to Book Ratio 4.94
Return on Assets (%) 15.59
Return on Capital (%) 19.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1643.44
Total Assets 3900.51
Total Liabilities 3900.51
Total Equity 2864.41
Share Outstanding 45750372
Price to Book Ratio 6.95
Return on Assets (%) 15.70
Return on Capital (%) 21.37
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1115.10
Total Assets 3265.90
Total Liabilities 3265.90
Total Equity 2393.04
Share Outstanding 45750372
Price to Book Ratio 8.64
Return on Assets (%) 15.23
Return on Capital (%) 20.77
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2219.87
Total Assets 4405.40
Total Liabilities 4405.40
Total Equity 3395.49
Share Outstanding 45750372
Price to Book Ratio 5.42
Return on Assets (%) 11.55
Return on Capital (%) 14.98
Particulars MAR 2024 (Values in Cr)
Net Income 746.07
Cash from Operations 410.66
Cash from Investing 53.70
Cash from Financing -235.14
Net change in Cash 75.40
Free Cash Flow 429.59
Particulars MAR 2023 (Values in Cr)
Net Income 824.01
Cash from Operations 658.26
Cash from Investing -36.05
Cash from Financing -345.79
Net change in Cash -26.16
Free Cash Flow 723.24
Particulars MAR 2022 (Values in Cr)
Net Income 772.89
Cash from Operations 893.00
Cash from Investing -575.02
Cash from Financing -180.51
Net change in Cash -88.45
Free Cash Flow 908.31
Particulars MAR 2021 (Values in Cr)
Net Income 668.72
Cash from Operations 631.47
Cash from Investing -468.84
Cash from Financing -1571.07
Net change in Cash -1612.58
Free Cash Flow 649.17
Particulars MAR 2020 (Values in Cr)
Net Income 642.49
Cash from Operations 536.47
Cash from Investing 1530.32
Cash from Financing -163.52
Net change in Cash 1689.98
Free Cash Flow 553.36
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 32.10 3.04 428.00 37.54 / 77.70
BLISS GVS PHARMA LTD 120.75 15.11 1.25 1271.52 92.25 / 148.95
CIPLA LTD 1471.35 25.74 4.18 118825.56 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 331.20 115.00 3.35 974.75 145.00 / 354.60
GLAXOSMITHKLINE PHARMA LT 2436.25 51.47 24.67 41271.55 1565.05 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 48.57 9.49 428.00 37.54 / 77.70
AMRUTAJAN HEALTH LTD 720.90 43.85 6.99 2084.17 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6497.50 126.19 23.91 16243.75 4050.15 / 8139.85
BLISS GVS PHARMA LTD 120.75 15.72 1.24 1271.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 5197.70
  • 26 Days 5347.20
  • 10 Days 5218.50
  • 50 Days 5518.50
  • 12 Days 5206.80
  • 100 Days 5388.60
  • 20 Days 5284.10
  • 200 Days 4462.70
5204.17
PIVOT
First Resistance 5273.33
Second Resistance 5368.12
Third Resistance 5437.28
First Support 5109.38
Second Support 5040.22
Third Support 4945.43
RSI 48.69
MACD -140.43
Commodity Channel Index (CCI) -47.16
ADX 44.65
Williams % R -59.84

Over 1 Month

down

-7.49

Over 3 Months

down

-11.60

Over 6 Months

down

18.16

Over 1 Year

down

29.88

Over 3 Years

down

1.62

Over 5 Years

down

5.01

PFIZER LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

PFIZER LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
22.1
Promoter Holdings
63.92
FII
3.53
DII
10.42
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Pfizer East India B V Shareholding of Promoter and Promoter Group 1.8186334E7 39.75
Wyeth Llc Shareholding of Promoter and Promoter Group 5617707.0 12.28
Life Insurance Corporation Of India Public Shareholding 1969892.0 4.31
Nippon Life India Trustee Ltd - A/c Nippon India Pharma Fund Public Shareholding 1719996.0 3.76
Wyeth Holdings Corporation Shareholding of Promoter and Promoter Group 1630164.0 3.56
Warner-lambert Company Llc Shareholding of Promoter and Promoter Group 1187163.0 2.6
Atul Limited Public Shareholding 958927.0 2.1
Parke, Davis & Company Llc Shareholding of Promoter and Promoter Group 955733.0 2.09
Quant Mutual Fund - Quant Esg Equity Fund Public Shareholding 953571.0 2.08
John Wyeth & Brother Ltd Shareholding of Promoter and Promoter Group 882000.0 1.93
Pharmacia Corporation Shareholding of Promoter and Promoter Group 783941.0 1.71
Sbi Magnum Midcap Fund Public Shareholding 599426.0 1.31

PFIZER LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-08-11 35.0 Final 2023-08-11 Equity shares 2023-08-11 5.0 Special 2023-08-11 Equity shares 2022-09-19 30.0 Special 2022-02-20 Equity shares 2022-08-18 35.0 Final 2022-08-19 Equity shares 2021-08-11 30.0 Final 2021-08-13 Equity shares 2021-08-11 5.0 Special 2021-08-13 Equity shares 2020-08-27 10.0 Final 2020-08-29 Equity shares 2020-05-06 320.0 Special 2020-05-08 Equity shares 2019-08-01 22.5 Final 2019-08-03 Equity shares 2018-08-29 20.0 Final 2018-08-31 Equity shares 2017-08-22 15.0 Final 2017-08-24 Equity shares 2017-08-22 5.0 Special 2017-08-24 Equity shares 2016-06-27 15.0 Final 2016-06-29 Equity shares 2015-07-03 12.5 Final 2015-07-07 Equity shares 2013-12-05 360.0 Interim 2013-12-06 Equity shares 2013-08-28 12.5 Final 2013-08-30 Equity shares 2013-08-28 20.0 Special 2013-08-30 Equity shares 2012-07-24 12.5 Final 2012-07-26 Equity shares 2011-07-08 4.0 Final 2011-07-12 Equity shares 2011-01-20 12.5 Interim 2011-01-21 Equity shares 2010-04-15 12.5 Final 2010-04-17 Equity shares 2009-03-31 12.5 Final 2009-04-06 Equity shares 2008-04-03 12.5 Interim 2008-04-07 Equity shares 2008-04-03 15.0 Special 2008-04-07 Equity shares 2007-03-09 22.5 Final 2007-03-13 Equity shares 2006-04-10 0.0 Final 2006-04-13 Equity shares
Ex-Date Ex-Bonus Ratio
2000-06-28 2000-06-12 1:1
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About PFIZER LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by PFIZER LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Pfizer Ltd?

Answer Field

The share price of Pfizer Ltd for NSE is ₹ 5127.9 and for BSE is ₹ 5122.75.

What is the Market Cap of Pfizer Ltd?

Answer Field

The market cap of Pfizer Ltd for NSE is ₹ 2,34,74.50 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Pfizer Ltd?

Answer Field

The 52 Week High and Low of Pfizer Ltd for NSE is ₹ 6451.15 and ₹ 3950.00 and for BSE is ₹ 6452.85 and ₹ 3977.00.

How to Buy Pfizer Ltd share?

Answer Field

You can trade in Pfizer Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Pfizer Ltd?

Answer Field

The 1 year returns on the stock has been 29.88%.

What is the Current Share Price of Pfizer Ltd?

Answer Field

Pfizer Ltd share price is for NSE ₹ 5127.9 & for BSE ₹ 5122.75 as on Nov 21 2024 03:29 PM.

What is the Market Cap of Pfizer Ltd Share?

Answer Field

The market cap of Pfizer Ltd for NSE ₹ 2,34,74.50 & for BSE ₹ 0.0 as on Nov 21 2024 03:29 PM.

What is the P/E Ratio of Pfizer Ltd Share?

Answer Field

As on Nov 21 2024 03:29 PM the price-to-earnings (PE) ratio for Pfizer Ltd share is 38.38.

What is the PB ratio of Pfizer Ltd Share?

Answer Field

As on Nov 21 2024 03:29 PM, the price-to-book (PB) ratio for Pfizer Ltd share is 819.90.

How to Buy Pfizer Ltd Share?

Answer Field

You can trade in Pfizer Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Pfizer Ltd Share on Bajaj Broking App?

Answer Field

To buy Pfizer Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Pfizer Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader